PORTLAND, Maine –Putney, Inc., a rapidly growing veterinary pharmaceutical company focused on the development and sale of generic prescription medicines for pets, has been named Portland’s 2013 Business of the Year in recognition of the company’s contribution to Portland’s economic growth.
This is the fifth major award that the company has won in the last six months. Previous recognition of Putney’s growth includes being named to the Inc. 5000 list and the Deloitte Technology Fast 500. Putney has also been recognized for its excellent workplace culture in 2013 by being named the number one best place to work in Maine and appearing in Fortune magazine, listed as the Tenth Best Small/Medium Workplace in the United States.
Jean Hoffman, president and CEO of Putney, says the two types of awards – company growth and positive workplace culture – go hand in hand. “Putney team members thrive on meeting big challenges, making a real difference in pet healthcare and creating a collaborative, encouraging work environment. During 2013, we’ve launched three more FDA Center for Veterinary Medicine-approved products from our pipeline of over twenty additional products, we’ve won several prestigious awards and we’ve added twenty-seven new team members. It has been an excellent year for all of us at Putney,” says Hoffman in a press statement.
Putney is a pharmaceutical company committed to providing high quality, cost-effective generic medicines for pets. Putney’s reliable supply of affordable drug options empowers veterinarians, allowing them to provide the right medicine at the best possible price, and supports pet owners, helping them afford to comply with veterinary recommendations. Putney’s ongoing investment in research and development is focused on creating the next generation of generic veterinary products based on inputs from companion animal veterinarians and its industry partners. Learn more at www.putneyvet.com.